Pegylated interferon lambda-1a
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pegylated interferon lambda-1a, covering 2015-10-09 to 2023-06-13. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV [Phase 3]